Adenosine 51662-1631
Product NDC
51662-1631- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 28, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA078686
Need to source Adenosine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adenosine | 3 mg/mL |
Drug Class
Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonists [MoA]
Packaging Options(1)
2 mL in 1 VIAL, SINGLE-DOSE (51662-1631-1)